ADVERTISEMENT
site_logo
  • Campus
  • Happening
  • Opinion
  • People
  • News
  • #BeInspired
  • Careers
  • 40 under 40
  • Exams
  • What The FAQ
  • Videos
    • Straight Up
    • Odisha Literary Festival 2020
    • Campus Convo
    • Careers After Corona
    • Express Expressions
    • Q&A With Prabhu Chawla
    • ThinkEdu Awards 2020
  • edex_worksEDEXWORKS
ADVERTISEMENT
COVID-19

Published: 22nd July 2020     

Researchers develop new tools to rapidly test COVID-19 antibodies

According to the study, the research team developed a number of safer, surrogate viruses that can be used in place of COVID-19 to test the neutralising activity of antibodies

Edex Live
Edex Live
f_icon t_icon i_icon l_icon koo_icon whatsapp_icon email_icon

Share Via Email

Unknown

COVID-19

Researchers have developed new tools to rapidly test the ability of antibodies to neutralise SARS-CoV-2, the novel coronavirus responsible for the COVID-19 pandemic.

The approach, published in the Journal of Experimental Medicine (JEM), will help researchers understand whether patients are susceptible to reinfection by COVID-19 and assess the effectiveness of experimental vaccines, as well as develop antibody-based therapies against the disease.

People infected with COVID-19 produce neutralising antibodies that prevent the virus from infecting cells by binding to the spike protein on the virus's surface.

Early studies have suggested that the strength of this antibody response varies greatly between patients, and it remains unknown how long any such neutralising antibodies persist in the blood to provide protection against reinfection.

"Whether elicited by natural infection or vaccination or administered as a convalescent plasma or in recombinant form, neutralising antibodies will likely be crucial for curtailing the global burden of COVID-19 disease," said study researcher Paul D Bieniasz from the Rockefeller University in the US.

"For this reason, the availability of rapid, convenient, and accurate assays that measure neutralising antibody activity is crucial for evaluating naturally acquired or artificially induced immunity against COVID-19," Bieniasz added.

According to the study, the research team developed a number of safer, surrogate viruses that can be used in place of COVID-19 to test the neutralising activity of antibodies targeting the coronavirus spike protein.

The surrogate viruses are versions of either the human immunodeficiency virus type-1 (HIV-1) or vesicular stomatitis virus (VSV) that produce the SARS-CoV-2 spike protein instead of their own surface proteins.

Some of these surrogate viruses are unable to replicate, making them even safer to use in the laboratory.

Moreover, the viruses are engineered to generate fluorescent or luminescent infected cells, making it easy for researchers to track infection and measure how well this process is blocked by potential neutralising antibodies.

The researchers tested the ability of convalescent patient plasma samples and purified antibodies to block the entry of the surrogate viruses into human cells grown in the laboratory.

"Each of the surrogate virus-based assays generated quantitative measurements of neutralising activity that correlated well with neutralisation measured using authentic SARS-CoV-2," said study author Theodora Hatziioannou.

"We think that these surrogate viruses and assays will be of significant use in curtailing the COVID-19 pandemic," the researchers concluded.

telegram
TAGS
COVID-19

O
P
E
N

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
telegram
ADVERTISEMENT
Write to us!

If you have campus news, views, works of art, photos or just want to reach out to us, just drop us a line.

newsletter_icon
Mailbox
edexlive@gmail.com
fb_icon
Facebook
twitter_icon
Twitter
insta_icon
Instagram
ADVERTISEMENT
Facebook
ADVERTISEMENT
Tweets by Xpress_edex
ADVERTISEMENT
ADVERTISEMENT

FOLLOW US

Copyright - edexlive.com 2021

The New Indian Express | Dinamani | Kannada Prabha | Samakalika Malayalam | Indulgexpress | Cinema Express | Event Xpress

Contact Us | About Us | Privacy Policy | Terms of Use | Advertise With Us

Home | Live Now | Live Story | Campus Trip | Coach Calling | Live Take